针对小细胞肺癌免疫治疗的新目标取得进展
Zitong Zheng1, Juanjuan Liu2, Junling Ma3
1Department of Oncology, Binzhou Medical University Hospital, Binzhou, P.R. China.
Thoracic cancer
|December 14, 2023
概括
小细胞肺癌 (SCLC) 在有限的治疗方法下仍然具有侵略性. 本综述探讨了DLL3,TIGIT,LAG-3和GD2等新型免疫治疗点,以提高患者的生存率.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 分子生物学分子生物学
背景情况:
- 小细胞肺癌 (SCLC) 是一种具有不良预后和有限治疗选择的侵袭性恶性瘤.
- 标准化疗仅提供适度的生存益处,治疗后复发率高.
- 目前的免疫疗法 (PD-1/PD-L1,CTLA-4) 在改善SCLC患者存活率方面表现出有限的疗效.
研究的目的:
- 审查新兴的SCLC免疫疗法点.
- 探索DLL3,TIGIT,LAG-3和GD2作为新型治疗点的潜力.
- 通过免疫治疗确定改善SCLC治疗结果的策略.
主要方法:
- 对当前SCLC治疗和免疫疗法的文献综述.
- 对SCLC中新出现的分子点的分析.
- 探索用于SCLC免疫治疗的新药机制.
主要成果:
- DLL3,TIGIT,LAG-3和GD2被确定为SCLC免疫治疗的有希望的标.
- 这些目标代表了克服当前治疗方法局限性的潜在途径.
- 对这些目标的进一步研究可能会产生改进的治疗策略.
结论:
- 新型免疫疗法点对于推进SCLC治疗至关重要.
- 针对DLL3,TIGIT,LAG-3和GD2提供了改善患者治疗结果的潜力.
- 开发具有新机制的药物对于未来的SCLC免疫疗法成功至关重要.
更多相关视频
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019
10.6K
07:42Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
Published on: February 7, 2021
5.0K
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Tumor Immunotherapy
529
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529
Cancer Vaccines
376
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
376
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
